Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
Neuropharmacology. 2019 Mar 15;147:11-27. doi: 10.1016/j.neuropharm.2018.05.035. Epub 2018 Jun 1.
Neuropharmacology. 2019.
PMID: 29907424
Review.